Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1993

Primary Completion Date

May 31, 2010

Conditions
LeukemiaMyelodysplastic Syndromes
Interventions
DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

dexamethasone

DRUG

etoposide

DRUG

idarubicin

DRUG

mitoxantrone hydrochloride

DRUG

thioguanine

PROCEDURE

allogeneic bone marrow transplantation

RADIATION

radiation therapy

Trial Locations (23)

1020

Hopital Universitaire Des Enfants Reine Fabiola, Brussels

1090

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels

2020

Algemeen Ziekenhuis Middelheim, Antwerp

4000

Centre Hospitalier Regional de la Citadelle, Liège

4200

Hospital Escolar San Joao, Porto

4420

Clinique de l'Esperance, Montegnée

14033

CHU de Caen, Caen

25030

CHR de Besancon - Hopital Saint-Jacques, Besançon

31026

Hopital des Enfants (Purpan Enfants), Toulouse

34295

Hopital Arnaud de Villeneuve, Montpellier

38043

CHR de Grenoble - La Tronche, Grenoble

44093

CHR Hotel Dieu, Nantes

49033

Centre Hospitalier Regional et Universitaire d'Angers, Angers

51092

Hopital Americain, Reims

59037

Centre Hospitalier Regional de Lille, Lille

67098

Hopital Universitaire Hautepierre, Strasbourg

69322

Hopital Debrousse, Lyon

75019

Hopital Robert Debre, Paris

75248

Institut Curie - Section Medicale, Paris

86021

Hopital Jean Bernard, Poitiers

B-9000

Universitair Ziekenhuis Gent, Ghent

B-3000

U.Z. Gasthuisberg, Leuven

06189

Centre Antoine Lacassagne, Nice

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00002517 - Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter